{"title": "Is Therapeutic Germline Editing Value-Based Healthcare? An Early He...", "author": "Pennestr\u00ec; Federico", "url": "http://journals.openedition.org/phenomenology/583", "hostname": "openedition.org", "description": "1. Introduction Psychophysical functions and social capabilities are given special value as long as they allow people to achieve what they hold most important in life (Sen, 1993). This is why healt...", "sitename": "Rosenberg & Sellier", "date": "2020-12-01", "cleaned_text": "Adams, R., Reiss, B., & Serlin, D. (2015). Disability. In R. Adams, B. Reiss & D. Serlin. Multiculturalism in the United States: A comparative guide to acculturation and ethnicity (pp. 5-11). New York, NY: New York University Press; Alexander, S. (1962, November 9). They Decide Who Lives, Who Dies: Medical Miracle Puts Moral Burden on Small Committee, Life, 102-105; Altman, L., Zurynski, Y., Breen, C., Hoffman, T., & Woolfenden, S. (2018). A Qualitative Study of Health Care Providers' Perceptions and Experiences of Working Together to Care for Children With Medical Complexity (CMC). BMC Health Service Research, 18(1), 70. Doi: 10.1186/s12913-018-2857-8; Araki, M., & Ishii, T. (2014). International regulatory landscape and integration of corrective genome editing into in vitro fertilization. Reproductive Biology and Endocrinology, 108(12). Doi: 10.1186/1477-7827-12-108; Barrangou, Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007). CRISPR provides acquired resistance against viruses in prokaryotes. Science, 315(5819):1709-12. doi: [10.1126/science.1138140](https://doi-org.bibliosan.clas.cineca.it/10.1126/science.1138140); Benston, S. (2016). CRISPR, a Crossroads in Genetic Intervention: Pitting the Right to Health against the Right to Disability. Laws, 5(1). Doi: 10.3390/laws5010005; Beyret, E., Liao, H.-K., Yamamoto, M., Y., Erikson, G., Reddy, P., & Izpisua Belmonte, J. C. (2019). Singe-Dose CRISPR/Cas9 Therapy Extends Lifespan of Mice with Medicine, 25(3), 419-422. Doi: 10.1038/s41591-019-0343-4; Bognar, G., & Hirose, I. (2014). The ethics of health care rationing. An introduction. New York, NY: Routledge; Boorse, C. (1977). Health as a Theoretical Concept. Philosophy of Science Association, 44(4), 542-573; Brewerm A. (2018). \"We Were on Our Own\": Mother's Experiences Navigating the Fragmented System of Professional Care for Autism, Social Science and Medicine, 215,61-68. Doi: 10.1016/j.socscimed.2018.08.039; Buchanan, A., Brock, D. W., Daniels, N., & Wikler, D. (2000). From chance to choice. Genetics & Justice. Cambridge: Cambridge University Press; Calabresi, G., & Bobbitt, P. (1978). Tragic Choices. New York, NY: W W Norton & Co Inc.; Carroll, D. (2017). Genome Editing: Past, Present, and Future. Yale Journal of Biology and Medicine, 90(4), 653-659; Chekani-Azar, S., Gharib Mombeni, E., Birhan, M., & Yousefi, M. (2020). CRISPR/Cas9 gene editing technology and its application to the coronavirus disease (COVID-19), a review. Journal of Life Science and Biomedicine, 10, 1-9. Doi: 10.36380/scil.2020.jlsb1; Chen, C.D., Zeldich, E., Li, Y., Yuste, A., & Abraham, C. R. (2018). Activation of the anti-aging and cognition-enhancing gene Klotho by June 12). Real-Time Pursuit of Outcomes That Matter to Patients. NEJM (2017). Drawing the Line: Disability, Genetic Intervention and Bioethics. Laws, 6, 9. Doi: 10.3390/laws6030009; Costa, G., Bassi, M., Gensini, G. F., Marra, Nicelli, A. L., November 15). CRISPR gene-editing tested in a person for the first time. Nature. Retrieved from: [https://www-nature-com.bibliosan.clas.cineca.it/news/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988](https://www-nature-com.bibliosan.clas.cineca.it/news/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988); Daniels, N. (2008). Just Health. Meeting Health Needs Fairly. Cambridge: Cambridge Univeristy Press; Daniels, N., & Sabin, J. (2008). The Ethics of Accountability in Managed Care Reform. Health Affairs (Milwood), 17(5), 50-64. Doi: 10.1377/hlthaff.17.5.50; Davies, K., & Barrangou, R. (2020). COVID-19 and the CRISPR Community Response. The CRISPR Journal, 3, 66-67. Doi: 10.1089/crispr.2020.29092.rba; Davini, O. Roma: Nutrimenti; Do Rozario, L. (1997). Spirituality in the lives of people with disability and chronic illness: a creative paradigm of wholeness and reconstruction. Disability Rehabilitation, 19(10), 427-34. Doi: 10.3109/09638289709166568; European Commission. (2019). Expert Panel on Effective Ways of Investing in Health. Defining \"value in value-based healthcare\". Retrieved from: Treating Sickle Ceel Disease Beta-Thalassemia with CRISPR/Cas9 Gene Editing. Retrieved from: [https://www.prnewswire.com/news-releases/european-hematology-association-treating-sickle-cell-disease-and-beta-thalassemia-with-crisprcas9-gene-editing-630287013.html](https://www.prnewswire.com/news-releases/european-hematology-association-treating-sickle-cell-disease-and-beta-thalassemia-with-crisprcas9-gene-editing-630287013.html); Falzon, C. (2014, June). Wrongful Life & Wrongful Birth - Legal and Moral Issues. doi: [10.13140/RG.2.1.2156.4649](https://www.researchgate.net/deref/http%3A%2F%2Fdx.doi.org%2F10.13140%2FRG.2.1.2156.4649); Retrieved from: [https://www.researchgate.net/publication/281372405_Wrongful_Life_Wrongful_Birth_-_Legal_and_Moral_Issues](https://www.researchgate.net/publication/281372405_Wrongful_Life_Wrongful_Birth_-_Legal_and_Moral_Issues); Finnegan, G. (2017, May 23). Outcomes that matter to patients derive more value from health budgets. Science Business. Retrieved from: [https://sciencebusiness.net/healthy-measures/news/outcomes-matter-pa](https://sciencebusiness.net/healthy-measures/news/outcomes-matter-pa); Foglia, E., Lettieri, R., C., & Croce, D. (2017). Technology Assessment in Hospitals: Lessons Learned From an Empirical Experiment. International Journal of Health Technology Assessment in Health Care, 33(2), 288-296. Doi: 10.1017/S0266462317000356; Frati, Montanari Vergallo, G., Zaami, S., & Busard\u00f2, F. P. (2015). Smart Drugs and Synthetic Androgens for Cognitive and Physical Enhancement: Revolving Doors 10.2174/1570159X13666141210221750; Glannon, the Biosciences, 6(1), 111-183. Doi: 10.1093/jlb/lsz010; Gumer, J. M. (2019). The Wisdom of Germline Editing: An Ethical Analysis of the Use of CRISPR-Cas9 to Edit Human Embryos. The New Bioethics: a multidisciplinary journal of biotechnology and the body, 25(2), 137-152. Doi: 10.1080/20502877.2019.1606151; Gupta, R. K., Abdul-Jawad, S., McCoy, L. E., Ping Mok, H., Peppa, D., Salgado, M., Martinez-Pciado, J., Nijhuis, M., Wensing, A. M. J., Lee, H., Grant, P., Nastouli, E., Lambert, J., Pace, M., Salasc, F., Monit, C., Innes, A. J., Muir, L., Walters, L., Frater, J., Lever, A. M. L., Edwards, S. G., Gabriel, I. H., & Olavarria, E. (2019). HIV-1 Remission Following CCR532/ 32 Haematopoietic Stem-Cell Transplantation, Nature, 568(7751), 244-248. Doi: 10.1038/s41586-019-1027-4; Hale, B. (2001). The value of life and the cost of living - Damages for wrongful birth. British Actuarial Journal, 7(5), 747-763; Haworth, K. G., Peterson, C. W., & Kiem, H. P. (2017). CCR5-edited gene therapies for HIV cure: Closing the door to viral entry. Cytotherapy, 19, 1325-1338. Doi: 10.1016/j.jcyt.2017.05.013; He, J. (2018, November 26). Lulu and Nana: Twin girls born healthy after gene surgery as single-cell embryos. Retrieved from: [https://www.youtube.com/watch?v=th0vnOmFltc](https://www.youtube.com/watch?v=th0vnOmFltc); Huang, Z., Tomitaka, A., Raymond, A., & Nair, M. (2017). Current application of CRISPR/Cas9 gene-editing technique Gene T., & Thiel, E. (2009). Transplantation of selected of transgenic blood stem cells - a future treatment for HIV/AIDS? Journal of International AIDS Society, 12(10). Doi: 10.1186/1758-2652-12-10; Hyry, H. I., Manuel, J., Cox, M. T., & Roos, J. C. P. (2015). Compassionate use of orphan drugs. Orphanet Journal of Rare Disease, 10(100). Doi: 10.1186/s13023-015-0306-x; Istituto Nazionale di Statistica (Istat), & United Nations International Children's Emergency Fund E., & Krahn, M. Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. Pharmacoeconomics, 35(7),727-740. Doi: 10.1007/s40273-017-0509-1; Jamal Anjum Official. (2020, January 31). ways to defeat Corona virus. Retrieved from: [https://www.youtube.com/watch?v=1mx5_eV2nAM](https://www.youtube.com/watch?v=1mx5_eV2nAM); Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonucleases in adaptive bacterial immunity, Science, 337(6096):816-821. Doi: 10.1126/science.1225829; J\u00f8rgensen, J., & Kefalas, P. (2017). Annuity Payments can increase patient access to innovative cell and gene therapies under England's net budget impact test. Journal of Market Access & Health Policy, 5(1), 1355203. Doi: 10.1080/20016689.2017.1355203; Kamm, F. M. (2013). Bioethical Prescriptions: To Create, End, Choose, and Improve Lives. New York, NY: Oxford University Press; Kang, X., He, W., Huang, Y., Yu, Q., Chen, Y., Gao, X., Sun, X., & Fan, Y. (2016). Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing. J Assist Reprod Genet, 33(5), 581-588; King, A. (2020, February 20). Detailed 3D coronavirus spike map offers hope for vaccine development [Royal Society of Chemistry]. Retrieved from: [https://www.chemistryworld.com/news/detailed-3d-coronavirus-spike-map-offers-hope-for-vaccine-development/4011226.article](https://www.chemistryworld.com/news/detailed-3d-coronavirus-spike-map-offers-hope-for-vaccine-development/4011226.article); Kluytmans, A., Tummers, M., van der Wilt, G. J., & Grutters, J. (2019). Early Assessment of Proof-of-Problem to Guide Health Innovation. Value Health, 22(5), 601-606; Kristensen, F. B., Lampe, K., Chase, D. L., Lee-Robin, S. H., Wild, C., Moharra, M., Velasco Garrido, Nielsen, C., R\u00f8ttingen, J.-A., Allgurin Neikter, S., Bistrup, M. L., & European Network for Health Technology Assessment. (2009). Practical Tools and Methods for Health Technology Assessment in Europe: Structure, Methodologies, and Tools Developed by the European Network for Health Technology Assessment, EUnetHTA. International Journal of Technology Assessment in Health Care, 25 Suppl 2, 1-8. Doi: 10.1017/S0266462309990626; Lander, E. S., Baylis, F., Zhang, F., Charpentier, E., Berg, P., Bourgain, C., Friedrich, B., Keith Joung, J., Li, J., Liu, D., Naldini, N., Nie, J. B., Qiu, R., Schoene-Seifert, B., Shao, F., Terry, S., Wei, W., & Winnacker, E.L. (2019, March 13). Adopt a moratorium on heritable genome editing. Retrieved from: [https://www-nature-com.bibliosan.clas.cineca.it/articles/d41586-019-00726-5](https://www-nature-com.bibliosan.clas.cineca.it/articles/d41586-019-00726-5); Lavazza, A. (2019). Parental Selective Reproduction: Genome-Editing and Maternal Behavior as a Potential Concern. Frontiers in Genetics, 10, 532. Doi: 10.3389/fgene.2019.00532; Lawless, M. T., Marshall, A., Mittinty, M. M., & Harvey, G. (2020). What Does Integrated Care Mean From an Older Person's Perspective? A Le Fanu, J. (2011). Rise & Fall of Modern Medicine. London: Abacus; Lega Italiana per la Lotta Rhun, A., Escalera-Maurer, Biology, 16(4), 380-389. doi: 10.1080/15476286.2019.1582974; Liang, P., Xu, Y., Zhang, X., Ding, C., Huang, R., Zhang, Z., Ly, J., Xie, X., Chen, Y., Li, Y., Sun, Y., Bai, Y., Songyang, Z., Ma, W., Zhou, C., & Huang, J. (2015). CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes, Protein cell, 6, 363-372; Lim K. R. Q., Yoon C., & Yokota T. (2018). Applications of CRISPR/Cas9 for the Treatment of L.M. (2011). Facial attractiveness: evolutionary based research. Philosophical Transactions of the Royal Society B: Biological Sciences, 366(1571), 1638-1659. Doi: [10.1098/rstb.2010.0404](https://dx-doi-org.bibliosan.clas.cineca.it/10.1098%2Frstb.2010.0404); Loureiro, A. & da Silva, G. J. (2019). CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool, Antibiotics (Basel), 8(1), pii: procurement: a users' guide to improving outcomes and delivering efficiencies in the UK. MedTech Views. Retrieved from: [http://www.medtechviews.eu/article/value-based-procurement-users-guide-improving-outcomes-and-delivering-efficiencies-uk](http://www.medtechviews.eu/article/value-based-procurement-users-guide-improving-outcomes-and-delivering-efficiencies-uk); Marangi, M. & Pistritto, G. (2018). Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique. Front Pharmacol, 9, 396. doi: 10.3389/fphar.2018.00396; Marraffini, L. A. (2016). The CRISPR-Cas system of Streptococcus pyogenes: function and applications. Stevens D.L., Fischetti V.A. (Eds), Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City, OK: University of Oklahoma Health Sciences Center; McCabe, C., Claxton, K., & Culyer, A. J. (2008). The NICE Cost- Effectiveness Threshold: What It Is and What That Means. 26(9), and Washington Niccol, A. (1997). Gattaca. United States: Columbia; Organization for the Economic Cooperation and Development. (2015, September 24). Healthcare costs unsustainable in advanced economies withour reform. Retrieved from: [https://www.oecd.org/health/healthcarecostsunsustainableinadvancedeconomieswithoutreform.htm](https://www.oecd.org/health/healthcarecostsunsustainableinadvancedeconomieswithoutreform.htm); Outram, S. M. (2010). The Use of Methylphenidate Among Students: The Future of Enhancement? Journal of Medical Ethics, 36 (4): 198-202; doi: 10.1136/jme.2009.034421; Penn Medicine News (2019, November 6). Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach. Retrieved from: [https://www.pennmedicine.org/news/news-releases/2019/november/results-first-us-trial-crispr-edited-immune-cells-cancer-patients-safety-of-approach](https://www.pennmedicine.org/news/news-releases/2019/november/results-first-us-trial-crispr-edited-immune-cells-cancer-patients-safety-of-approach); Pennestr\u00ec, F. G., & Banfi, G. (2019). Pay less and spend more - the real value in healthcare procurement. Annals of Translational Medicine, 7, 688. di Politeia, 128, 60-73; Porter, R. (2011). The Cambridge Illustrated History of Medicine. Cambridge: Cambrigde University Press. Radaelli, G., Lettieri, E., Masella, C., Merlino, L., Strada, A., & Tringali, M. (2014). Implementation of EuNetHTA Core Model in Lombardia: The VTS Framework. International Journal of Technology Assessment in Health Care, 30(1), 105-112. Doi: 10.1017/S0266462313000639; Rawls, J. (1971). A Theory of Cambridge: The Belknap Press of Harvard University; Milano: Polis. Reichman, N. E., Corman, H., & Noonan, K. (2008). Impact of Child Disability on the Family. Maternal Child Health Journal, 12(6), 679-83. Doi: 10.1007/s10995-007-0307-z; Sample, I. (2019, December 31). Chinese scientists who edited babies' genes jailed for three years. Retrieved from: [https://www.theguardian.com/world/2019/dec/30/gene-editing-chinese-scientist-he-jiankui-jailed-three-years](https://www.theguardian.com/world/2019/dec/30/gene-editing-chinese-scientist-he-jiankui-jailed-three-years); Santas, G. (2019). CRISPR and the Ethics of Gene Editing: A Modest Framework for Discussion. International Journal of Clinical Research & Trials, 4, 138. Doi: 10.15344/2456-8007/2019/138; Scanlon, M. L., & Vreeman, R. C. (2013). Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV/AIDS (Auckland), 5,1-17. Doi: 10.2147/HIV.S28912; Sen, A. (1993). Capability and Well-Being. In M., Nussbaum & A. Sen (Eds), The Quality of Life (pp. 30-53). Oxford: Clarendon Press; Signorelli, C., & Fara, G. M. (2020). COVID-19: Hygiene and Public Health The Conquest of Death. A controversial look on medicine and why we may be the last generation to die. New York, NY: Macmillan; Soni, S. (2020, May 21). COVID-19 and gene editing: ethical and legal considerations. The Conversation. Retrieved from: [https://theconversation.com/covid-19-and-gene-editing-ethical-and-legal-considerations-138164](https://theconversation.com/covid-19-and-gene-editing-ethical-and-legal-considerations-138164); Tang, L., Zeng, Y., Du, H., Gong, M., Peng, J., Zhang, B., Lei, M., Zhao, F., Wang, W., Li, X., & Liu, J. (2017). CRISPR/Cas9-mediated gene editing in human zygotes using S., Sasso, E., Viscoli, C., & Di Biagio, A. (2018). How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy. BMC Health Service Research, 18, 691. Doi: [10.1186/s12913-018-3507-x](https://dx-doi-org.bibliosan.clas.cineca.it/10.1186%2Fs12913-018-3507-x); Tebas, P., Stein, D., Tang, W. W., Frank, I., Wang, S. Q., Lee, G., Kaye Spratt, S., Surosky, R., T., Giedlin, M. A., Nichol, G., Holmes, M., C., Gregory, P. D., Ando, D., G., Kalos, M., Collman, R., G., Binder-Scholl, G., Plesa, G., Hwangm W-T., Levine, B., L., & Hune, C., H. (2014). Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV. New England Journal of Medicine, 370(10), 901-910. doi: [10.1056/NEJMoa1300662](https://dx-doi-org.bibliosan.clas.cineca.it/10.1056%2FNEJMoa1300662); Teff, H. (1985). The action for \"wrongful life\" in England and the United States. International Journal of Comparative Law Quarterly, 34, 423-41; The Associated Press-NORC Center for Public Affairs Research. (2018). Human Genetic Engineering. Retrieved from: [http://apnorc.org/projects/Pages/Human-Genetic-Engineering.aspx](http://apnorc.org/projects/Pages/Human-Genetic-Engineering.aspx); The HIV-Causal Collaboration (2010). The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS, 24: 123-127. Doi: [10.1097/QAD.0b013e3283324283](https://dx-doi-org.bibliosan.clas.cineca.it/10.1097%2FQAD.0b013e3283324283); The Fertility Institutes (2020). Choose Your Baby's Eye Color. Takind advantage of the ever-expanding role of modern genetics. Retrieved from: [https://www.fertility-docs.com/programs-and-services/pgd-screening/choose-your-babys-eye-color.php](https://www.fertility-docs.com/programs-and-services/pgd-screening/choose-your-babys-eye-color.php); Tsang, C., & Cho, S. (2018 January 22). Wrongful Pregnancy: UK Courts continue to refuse compensation for such claims on public policy grounds. Kennedys Law. Retrieved from: [https://www.kennedyslaw.com/](https://www.kennedyslaw.com/); Vachey, G. & D\u00e9glon, N. 10.1007/978-1-4939-7825-0_21; Van der Burg, W. (1991). The Slippery Slope Argument. Ethics, 102, 42-65; Van Leeuwen, C. M., Post, M. W., Westers, P., van der Woude, L. H., de Groot, S., Sluis, T., Slootman, H., & Lindeman, E. (2012). Relationships Between Activities, Participation, Personal Factors, Mental Health, and Life Satisfaction in Persons With Spinal Cord Injury. Archives of Physical Medicine and Rehabilitation, 93(1), 82-9. Doi: 10.1016/j.apmr.2011.07.203; Wang, C., Zhai, X., Zhang, X., Li, L., Wang, J., Liu, D-P., & Chinese Academy of Medical Sciences. (2019). Gene-edited Babies: Chinese Academy of Medical Sciences' Response 393(10166), 25-26. Doi: 10.1016/S0140-6736(18)33080-0; Weiseler, B., McGauran, N., & Kaiser, T. (2019). New drugs: where did we go wrong and what can we do better? The British Medical Journal, 366, l4340. Doi: 0.1136/bmj.l4340; World Health Organization (2020, January 30). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Retrieved from: [https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)](https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)); World Health Organization (2007). Sixtieth World Health Assembly: Health technologies. Retrieved from: [https://www.who.int/healthsystems/WHA60_29.pdf?ua=1](https://www.who.int/healthsystems/WHA60_29.pdf?ua=1); Xie, Y, Zhan, S., Ge, W., & Tang, P. (2019). The Potential Risks of C-C Chemokine Receptor 5-edited Babies in Bone Development. Bone Research, 7(4). Doi: 10.1038/s41413-019-0044-0; Xu, M. M. (2020). CCR5-32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool. Cell Bioscience, 10, 48. Doi: 10.1186/s13578-020-00410-6; Zangrillo, A., & Gattinoni, L. (2020). Learning From Mistakes During the Pandemic: The Lombardy Lesson. Intensive Care Medicine, 1-2. Doi: 10.1007/s00134-020-06137-9; Zou, S., Glynn, S., Kuritzkes, D., Shah, M., Cook, N., Berliner, N., & NHLBI AIDS Blood Session Group. (2013). Hematopoietic Cell Transplantation and HIV Cure: Where We Are "}